Atlas FDA

GORE Cardioform Septal Occluder and GORE Cardioform ASD Occluder

FDA premarket approval P050006/S089 · decided 2021-01-26

Approval details

PMA number
P050006
Supplement
S089
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
GORE Cardioform Septal Occluder and GORE Cardioform ASD Occluder
Generic name
Transcatheter septal occluder
Applicant
W. L. Gore & Associates, Inc.
Date received
2021-01-15
Decision date
2021-01-26
Days to decision
11 days
Decision code
OK30
Product code
MLV
Advisory committee
Cardiovascular
Expedited review
No
Location
Phonix, AZ
Statement
Site changes to the LAL testing requirement and removal of cytotoxicity and infrared spectroscopy inspections for incoming components.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05